An experimental compound reduced complications of type 1 and type 2 diabetes in mice — not by lowering blood sugar — but by countering its consequences, a new study finds.
An experimental compound reduced complications of type 1 and type 2 diabetes in mice — not by lowering blood sugar — but by countering its consequences, a new study finds.